Click this link to view company snapshots Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Elscint Announces Change of the Board of Directors

    HAIFA, Israel, May 4 /PRNewswire/ -- Elscint Ltd. (NYSE: ELT), a
subsidiary of Elbit Medical Imaging Ltd. (Nasdaq: EMITF), announced today that
following the closing of the sale of Elron Electronic Industries Ltd.
(Nasdaq: ELRNF) shares in Elbit Medical Imaging Ltd. to Europe Israel (MMS
Ltd.) the following directors were appointed to Elscint:

    * Mordechai Zisser -- Chairman and President of Europe Israel Ltd.
    * Gideon Bar On -- General Manager, Adam Bar On Ltd. (a real estate
      company)
    * Ephraim Bernad -- General Manager, Softov Ltd. (a software company)
    * Amos Pickel, Esq. -- President, Red Sea Hotels
    * Shimon Yitzchaki -- VP Europe Israel
    * Rachel Lavine -- VP Europe Israel

    It was also announced that the following Elscint directors have resigned
from office: Uzia Galil, Yigal Baruchi, Dr. Michael Enghel, Amos Horev, and
Prof. Ernest Lubin.
    Internet home page: http://www.elscint.co.il

    This release contains certain forward-looking statements which involve
known and unknown risks, uncertainties or other factors not under the
Company's control which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance or
other expectations implied by these forward-looking statements.  These factors
include, but are not limited to, those detailed in the Company's periodic
filings with the Securities and Exchange Commission.


SOURCE Elscint Ltd.




Back to Topback to top

Related links:
  • http://www.elscint.co.il
    CONTACT:
    Emmanuel Gill, Chairman of the Board of
    Elscint Ltd., 972-4-8550219; or General Information, Virginia St.
    John-Needham, 310-442-0599, Media Inquiries, Alicia
    Nieva-Woodgate, 415-986-1591, or Investor Inquiries, Brian Gill,
    212-661-8030, all of The Financial Relations Board
    NOTE TO EDITORS: For further information on Elscint, via
    facsimile at no cost, please call 1-800-PRO-INFO and enter
    company code 206 or ticker symbol ELT